D
Olema Pharmaceuticals, Inc. OLMA
$5.59 -$0.17-2.95% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses -6.75% -4.92%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 8.58% -5.15%
Operating Income -8.58% 5.15%
Income Before Tax -44.08% 9.47%
Income Tax Expenses -- --
Earnings from Continuing Operations -44.08% 9.47%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -44.08% 9.47%
EBIT -8.58% 5.15%
EBITDA -8.60% 5.20%
EPS Basic -43.97% 30.28%
Normalized Basic EPS -11.11% 30.29%
EPS Diluted -43.97% 30.28%
Normalized Diluted EPS -11.11% 30.29%
Average Basic Shares Outstanding 0.08% 29.84%
Average Diluted Shares Outstanding 0.08% 29.84%
Dividend Per Share -- --
Payout Ratio -- --